Price T Rowe Associates Inc Pliant Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 87,674 shares of PLRX stock, worth $116,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,674

Previous 4,634,486 98.11%

Holding current value

$116,606

Previous $61 Million 99.81%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$1.35 - $13.53 $6.14 Million - $61.5 Million	-4,546,812 Reduced 98.11%	87,674 $119,000
Q4 2024 Feb 14, 2025	SELL	$10.55 - $15.7 $2.11 Million - $3.15 Million	-200,327 Reduced 4.14%	4,634,486 $61 Million
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $2.45 Million - $3.34 Million	232,490 Added 5.05%	4,834,813 $54.2 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $6.81 Million - $10 Million	643,235 Added 16.25%	4,602,323 $49.5 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $2.45 Million - $3.39 Million	173,172 Added 4.57%	3,959,088 $59 Million
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $5.58 Million - $8.32 Million	434,429 Added 12.96%	3,785,916 $68.6 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $5.55 Million - $7.67 Million	380,554 Added 12.81%	3,351,487 $58.1 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $15.7 Million - $26.4 Million	864,689 Added 41.05%	2,970,933 $53.8 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $16.9 Million - $32.7 Million	900,510 Added 74.69%	2,106,244 $56 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $443,870 - $663,977	-26,110 Reduced 2.12%	1,205,734 $23.3 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $9.45 Million - $29.8 Million	1,231,844 New	1,231,844 $25.7 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $3.47 Million - $6.11 Million	-210,678 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$28.05 - $37.69 $97,585 - $131,123	-3,479 Reduced 1.62%	210,678 $6.14 Million
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $5.25 Million - $8.62 Million	214,157 New	214,157 $8.42 Million

Others Institutions Holding PLRX

# of Institutions

153

Shares Held

60.9M

Call Options Held

279K

Put Options Held

7.1K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $64.7M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Pliant Therapeutics, Inc. Transaction History